Dr. Joseph A. Samady, MD

Dr. Samady practices at Dermatology Specialists Inc in Oceanside, California.

Dr. Samady's NPI, 1013954908, was assigned on June 1, 2006. Dr. Samady graduated from Rutgers New Jersey Medical School in 1996. Dr. Samady holds California license A71411.

Dr. Samady's primary practice is Dermatology Specialists Inc, at 3629 Vista Way, Oceanside, CA 92056 in San Diego County. The practice phone is (760) 828-9200.

Dr. Samady's primary practice is Dermatology Specialists Inc in Oceanside, California. The medical group on file is Dermatology Specialists, Inc. Dmand AI also links Dr. Samady to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samady practices. Vendor and product names are available with a free account.

Dermatology is Dr. Samady's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Samady is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Samady's licenses on file in 2 states: California and New Jersey.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and itchy rashes among the conditions Dr. Samady treats.

CMS data shows 7,571 Medicare services from Dr. Samady across 21 procedure codes in 2024, for 1,455 Medicare patients. Medicare paid $351,939 for them. Every service was in an office.

CMS counts 1,455 Medicare patients who saw Dr. Samady in 2024. The largest group is 65 to 74, with 614 patients. 71% of them have high cholesterol, and 63% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Samady's median patient age at 70, with 51% women.

In 2024, Dr. Samady wrote 1,569 Medicare Part D claims for 719 patients. 90% of them were for generic drugs. CMS names the drug for 1,436 of them, across 24 drugs with 11 or more claims each, at $676,912 in total drug cost. In 2023, CMS named 972 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Samady for performance year 2024, reported as part of a group. Dr. Samady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,982 procedures of removal of skin lesions by Dr. Samady, more than 98% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Samady.

Dmand AI links Dr. Samady to 1 clinical trial. Conditions studied include Pruritus and Eczema.

CMS Open Payments shows 626 general payments to Dr. Samady from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Promius Pharma LLC paid the most, $4,655.

Dmand AI lists 2 awards for Dr. Samady, most recently CMS Stage 1 EHR in 2013.

Dr. Samady graduated from Rutgers New Jersey Medical School in 1996. Dr. Samady is a member of AAD.

Dr. Samady is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.